Morfin Abcur (Morphine Hydrochloride)

Morphine, the active ingredient in Morfin Abcur, is an opioid analgesic presented as an injectable solution for intramuscular, intravenous use. It treats severe acute pain, postoperative pain and cancer pain in adult patients, providing rapid and potent analgesia in hospital and oncology settings.

GNH USA supplies Morfin Abcur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide, with sourcing from the European Union market.

Morphine, an opioid analgesic, is used for managing severe pain through mu‑opioid receptor activation.

- Severe acute pain: provides rapid relief of intense, short‑term pain episodes. - Postoperative pain: controls pain following surgical procedures to facilitate recovery. - Cancer pain: alleviates chronic malignant pain in palliative and supportive care.

Morphine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: feeling of sickness often accompanied by vomiting. - Constipation: reduced bowel motility leading to hard stools. - Drowsiness: increased sleepiness or reduced alertness. - Itching: mild pruritus, especially at the injection site.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure causing dizziness or fainting. - Anaphylaxis: rare allergic reaction with rash, swelling, and airway compromise. - Serotonin syndrome: rare when combined with serotonergic agents, presenting with agitation, hyperthermia, and neuromuscular abnormalities.

Safe use of Morfin Abcur requires careful assessment and monitoring.

- Assess respiratory function: monitor breathing rate and oxygen saturation before and during therapy. - Evaluate renal and hepatic function: adjust dosing in patients with impairment. - Avoid use in severe asthma or existing respiratory depression: risk of additive respiratory compromise. - Use caution with concomitant central nervous system depressants: may enhance sedation and respiratory effects. - Store at ambient temperature: keep in original packaging, protect from moisture and light, and store below 25 °C.

Morphine can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension or serotonin syndrome. - Other opioids: additive respiratory depression and profound sedation. - CNS depressants (e.g., benzodiazepines, barbiturates): heightened risk of respiratory failure. - Respiratory depressants (e.g., anesthetic agents): may cause life‑threatening hypoventilation.

Moderate Interactions (Monitor Closely):\n- CYP3A4 inhibitors (e.g., ketoconazole): may increase morphine plasma levels. - Alcohol: can potentiate sedation and respiratory depression. - Antihistamines: may enhance drowsiness. - Certain antidepressants (e.g., SSRIs): monitor for signs of serotonin syndrome.